Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity.
Paciotti M, Diana P, Gallioli A, De Groote R, Farinha R, Ficarra V, Gaston R, Gontero P, Hurle R, Martínez-Piñeiro L, Minervini A, Pansadoro V, Van Cleynenbreugel B, Wiklund P, Casale P, Lughezzani G, Uleri A, Mottrie A, Palou J, Gallagher AG, Breda A, Buffi N. Paciotti M, et al. Among authors: uleri a. BJU Int. 2024 Jun 3. doi: 10.1111/bju.16433. Online ahead of print. BJU Int. 2024. PMID: 38830818
Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
Uleri A, Baboudjian M, Diamand R, Ploussard G. Uleri A, et al. Eur Urol. 2024 May 24:S0302-2838(24)02387-X. doi: 10.1016/j.eururo.2024.05.017. Online ahead of print. Eur Urol. 2024. PMID: 38796382 No abstract available.
Reply to Andrew J. Vickers' Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
Uleri A, Baboudjian M, Diamand R, Ploussard G. Uleri A, et al. Eur Urol. 2024 May 24:S0302-2838(24)02386-8. doi: 10.1016/j.eururo.2024.05.016. Online ahead of print. Eur Urol. 2024. PMID: 38796380 No abstract available.
Cumulative morbidity of ureteroscopy for upper tract urothelial carcinoma.
Basile G, Gallioli A, Territo A, Verri P, Gaya JM, Afferi L, Diana P, Sanz I, Dieguez L, Uleri A, Berquin C, Gavrilov P, Algaba F, Palou J, Breda A. Basile G, et al. Among authors: uleri a. Actas Urol Esp (Engl Ed). 2024 May 10:S2173-5786(24)00067-2. doi: 10.1016/j.acuroe.2024.05.007. Online ahead of print. Actas Urol Esp (Engl Ed). 2024. PMID: 38735432 English, Spanish.
Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis.
Moretto S, Saita A, Scoffone CM, Talso M, Somani BK, Traxer O, Angerri O, Knoll T, Liatsikos E, Herrmann TRW, Ulvik Ø, Skolarikos A, Cracco CM, Keller EX, Paciotti M, Piccolini A, Uleri A, Tailly T, Carmignani L, Pietropaolo A, Corrales M, Lughezzani G, Lazzeri M, Fasulo V, De Coninck V, Arena P, Nagele U, Ferretti S, Kronenberg P, Perez-Fentes D, Osther PJ, Goumas IK, Acquati P, Ajayi L, Diana P, Casale P, Buffi NM. Moretto S, et al. Among authors: uleri a. World J Urol. 2024 Apr 13;42(1):234. doi: 10.1007/s00345-024-04933-2. World J Urol. 2024. PMID: 38613692 Review.
Promoting Green In-Person Scientific Conferences.
Diana P, Pradere B, Uleri A, Baboudjian M. Diana P, et al. Among authors: uleri a. Eur Urol Focus. 2024 Apr 9:S2405-4569(24)00051-8. doi: 10.1016/j.euf.2024.03.007. Online ahead of print. Eur Urol Focus. 2024. PMID: 38600021 No abstract available.
47 results